Key takeaway
In 100 patients in atrial fibrillation and 100 in sinus rhythm, Apple and Samsung watch algorithms diagnosed AF better than Withings (sensitivity/specificity 87%/86% and 88%/81% vs 78%/80%, p < 0.05), mainly because Withings gave more inconclusive ECGs. Expert reading ranked the watches differently, and the patients were recorded in a clinical setting.
Study design
Research article
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Smartwatches can record a single-lead ECG, but their built-in algorithms and the readability of their tracings may differ between models. The authors compared how well three commercial smartwatches detect atrial fibrillation (AF), both by automated algorithm and by expert reading.
Who and how
Prospective, non-randomized, adjudicator-blinded clinical study of 100 patients in AF and 100 in sinus rhythm; patients with atrial flutter were excluded. Each patient had 4 ECG recordings in random order: a conventional 12-lead ECG, an Apple Watch Series 5, a Samsung Galaxy Watch Active 3 and a Withings Move ECG. Every smartwatch ECG was analyzed by the watch's own proprietary software and by clinical experts, who also graded tracing quality.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Automated AF diagnosis was more accurate with Apple and Samsung than with Withings (sensitivity/specificity 87%/86% for Apple and 88%/81% for Samsung vs 78%/80% for Withings, p < 0.05), driven by more inconclusive ECGs with Withings.
- 2Expert interpretation was more accurate for Withings and Apple than for Samsung (sensitivity/specificity 96%/86% for Withings and 94%/84% for Apple vs 86%/76% for Samsung, p < 0.05).
- 3The Samsung gap was driven by more uninterpretable tracings: 15% versus 2% and 4% for the other two (p < 0.05).
Limits & uncertainty
- 1Only 100 patients in AF and 100 in sinus rhythm, all recorded in a clinical setting, with atrial flutter excluded, so real-world use by people at home may perform differently.
- 2Only three models were tested; software and hardware versions change, so results may not hold for newer watches.
- 3The abstract does not say how inconclusive ECGs were counted in the accuracy figures beyond noting they reduced Withings' accuracy.
- 4This reading is based on the abstract only.
What to take from it
A smartwatch ECG can pick up atrial fibrillation, but which watch you have affects how often it gives an answer and how readable the trace is. A watch alert or recording is a prompt to see a clinician, not a diagnosis, and a normal result does not rule AF out.
Reading your own data
If your watch records ECGs, keep the recordings and note your symptoms, then share them with your clinician. Take recordings seated and still, the same way each time, and do not compare readings between different watch models.
How to read this evidence
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Aims
The diagnostic accuracy of proprietary smartwatch algorithms and the interpretability of smartwatch ECG tracings may differ between available models. We compared the diagnostic potential for detecting atrial fibrillation (AF) of three commercially available smartwatches.
Methods
We performed a prospective, non-randomized, and adjudicator-blinded clinical study of 100 patients in AF and 100 patients in sinus rhythm, patients with atrial flutter were excluded. All patients underwent 4 ECG recordings: a conventional 12-lead ECG, Apple Watch Series 5®, Samsung Galaxy Watch Active 3®, and Withings Move ECG® in random order. All smartwatch ECGs were analyzed using their respective automated proprietary software and by clinical experts who also graded the quality of the tracings.
Results
The accuracy of automated AF diagnoses by Apple and Samsung outperformed that of Withings, which was attributable to a higher proportion of inconclusive ECGs with the latter (sensitivity/specificity: 87%/86% and 88%/81% vs. 78%/80%, respectively, p < 0.05). Expert interpretation was more accurate for Withings and Apple than for Samsung (sensitivity/specificity: 96%/86% and 94%/84% vs. 86%/76%, p < 0.05), driven by the high proportion of uninterpretable tracings with the latter (2 and 4% vs. 15%, p < 0.05).
Conclusion
Diagnosing AF is possible using various smartwatch models. However, the diagnostic accuracy of their automated interpretations varies between models as does the quality of ECG tracings recorded for manual interpretation.
Sources & attribution
Smartwatch Electrocardiograms for Automated and Manual Diagnosis of Atrial Fibrillation: A Comparative Analysis of Three Models.
Abu-Alrub S, Strik M, Ramirez FD, Moussaoui N, Racine HP, Marchand H, Buliard S, Haïssaguerre M, Ploux S, Bordachar P.
Frontiers in cardiovascular medicine · 2022-02-04
DOI: 10.3389/fcvm.2022.836375 ↗PubMed · 35187135 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

